The tumor models were selected for their differential levels of P2X7 surface expression, ranging from very low, in the lung carcinoma model LLC, intermediate in the B16F10 melanoma model, to relatively high expression in the EG7 thymoma model (Figure 2A). Here, P2RX7 is linked to melanoma.